Entero Healthcare Solutions Limited (NSE:ENTERO)

Market Cap	51.08B -1.7%
Revenue (ttm)	65.91B +29.3%
Net Income	1.15B +21.3%
EPS	26.40 +21.3%
Shares Out	43.51M
PE Ratio	44.47
Forward PE	31.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,375
Open	1,205.00
Previous Close	1,205.40
Day's Range	1,169.10 - 1,211.60
52-Week Range	944.00 - 1,390.00
Beta	-0.61
Analysts	Strong Buy
Price Target	1,516.75 (+29.2%)
Earnings Date	Aug 7, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital the...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 4,111
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ENTERO

Financial Performance

In fiscal year 2026, NSE:ENTERO's revenue was 65.91 billion, an increase of 29.35% compared to the previous year's 50.96 billion. Earnings were 1.15 billion, an increase of 21.33%.

Analyst Summary

According to 4 analysts, the average rating for ENTERO stock is "Strong Buy." The 12-month stock price target is ₹1,517, which is an increase of 29.20% from the latest price.

Price Target

₹1,517

(29.20% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 17, 2026

Data Sources Report a data error